Free Trial
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price, News & Analysis

NanoVibronix logo
$3.07 -0.36 (-10.50%)
Closing price 04:00 PM Eastern
Extended Trading
$3.11 +0.04 (+1.30%)
As of 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NanoVibronix Stock (NASDAQ:NAOV)

Key Stats

Today's Range
$3.03
$3.43
50-Day Range
$0.24
$3.43
52-Week Range
$1.92
$13.97
Volume
710,229 shs
Average Volume
261,855 shs
Market Capitalization
$2.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Remove Ads

NanoVibronix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

NAOV MarketRank™: 

NanoVibronix scored higher than 3% of companies evaluated by MarketBeat, and ranked 932nd out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NanoVibronix.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NanoVibronix is -2.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NanoVibronix is -2.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NanoVibronix has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about NanoVibronix's valuation and earnings.
  • Percentage of Shares Shorted

    3.08% of the float of NanoVibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoVibronix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoVibronix has recently increased by 179.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NanoVibronix does not currently pay a dividend.

  • Dividend Growth

    NanoVibronix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.08% of the float of NanoVibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoVibronix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoVibronix has recently increased by 179.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NanoVibronix has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for NanoVibronix this week, compared to 0 articles on an average week.
  • Search Interest

    3 people have searched for NAOV on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NanoVibronix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.00% of the stock of NanoVibronix is held by insiders.

  • Percentage Held by Institutions

    Only 16.39% of the stock of NanoVibronix is held by institutions.

  • Read more about NanoVibronix's insider trading history.
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

NAOV Stock News Headlines

Is 2025 really the best time to get rich in American history?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
NanoVibronix announces UroShield health service study data published
NanoVibronix Inc trading halted, news pending
NanoVibronix announces 1 for 11 reverse stock split
See More Headlines

NAOV Stock Analysis - Frequently Asked Questions

NanoVibronix's stock was trading at $0.59 on January 1st, 2025. Since then, NAOV shares have increased by 450.7% and is now trading at $3.2490.
View the best growth stocks for 2025 here
.

NanoVibronix, Inc. (NASDAQ:NAOV) posted its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter. The business had revenue of $0.05 million for the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 101.17% and a negative net margin of 93.80%.

Shares of NanoVibronix reverse split on Friday, March 14th 2025. The 1-11 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL).

Company Calendar

Last Earnings
11/14/2018
Today
3/18/2025
Next Earnings (Estimated)
4/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NAOV
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,710,000.00
Pretax Margin
-93.04%

Debt

Sales & Book Value

Annual Sales
$3.29 million
Price / Cash Flow
N/A
Book Value
$1.95 per share
Price / Book
1.67

Miscellaneous

Free Float
3,489,000
Market Cap
$2.57 million
Optionable
Not Optionable
Beta
1.81
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:NAOV) was last updated on 3/18/2025 by MarketBeat.com Staff
From Our Partners